Product Information
GALBRIELA 0.8-0.025 MG CHEW TB is a generic product labeled by Xiromed LLC, priced at $1.2570 per EA under NDC 70700030685. Its NADAC has been published 54 times since Aug 13, 2025.
FDA first approved this application on Apr 23, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Xiromed LLCNDC
70700030685
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA203371FDA Approved
4/23/2014
TE Code
AB
On Market Since
1/29/2025
Price Statistics
The NADAC for GALBRIELA 0.8-0.025 MG CHEW TB has been published 54 times since Aug 13, 2025, and over the history we have for it it has declined 33.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2570 per EA |
|---|---|
| All-time high | $1.8990 (Aug 13, 2025) |
| All-time low | $1.2570 (Aug 19, 2026) |
| 52-week high | $1.8790 |
| 52-week low | $1.2570 |
| Median price | $1.7366 |
| Average price | $1.6343 |
| Largest weekly change | -12.6% (Apr 22, 2026) |
| Weeks tracked | 54 |
| Tracking since | Aug 13, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 59% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GALBRIELA 0.8-0.025 MG CHEW TB?
The current National Average Drug Acquisition Cost (NADAC) for GALBRIELA 0.8-0.025 MG CHEW TB, manufactured by Xiromed LLC, is $1.2570 per EA (NDC 70700030685), effective Aug 19, 2026.
How has the price of GALBRIELA 0.8-0.025 MG CHEW TB changed over time?
Over the history we have for it, the NADAC for GALBRIELA 0.8-0.025 MG CHEW TB has declined 33.8%. It has been tracked across 54 weekly CMS publications since Aug 13, 2025.
What are the highest and lowest recorded NADAC prices for GALBRIELA 0.8-0.025 MG CHEW TB?
Since Aug 13, 2025, the NADAC for GALBRIELA 0.8-0.025 MG CHEW TB has ranged from a low of $1.2570 (Aug 19, 2026) to a high of $1.8990 (Aug 13, 2025), with a median of $1.7366 per EA.
Are there cheaper alternatives to GALBRIELA 0.8-0.025 MG CHEW TB?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NORET-ESTR-FE 0.4-0.035(21)-75, is $0.5101 per EA — about 59% below GALBRIELA 0.8-0.025 MG CHEW TB.
Who manufactures GALBRIELA 0.8-0.025 MG CHEW TB?
GALBRIELA 0.8-0.025 MG CHEW TB (NDC 70700030685) is labeled by Xiromed LLC, and CMS classifies it as a generic product.